Navigation Links
Sanovas Awarded Patent for Abrading Balloon Catheter for Extravasated Drug Delivery
Date:12/3/2013

SAUSALITO, Calif., Dec. 3, 2013 /PRNewswire/ -- Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.

The Abrading Balloon Catheter for Extravasated Drug Delivery is a multi-lumen balloon catheter that features abrasive outer surfaces upon the substrate of the balloons that are intended to abrade tissue and stimulate cellular function to optimize the osmotic uptake of therapeutic agents into target tissues. The device temporarily occludes a specific region to create a localized treatment chamber for the focal and/or circumferential delivery of various types of therapeutic agents to treat a variety of disease states via the company's patented methods of extravasated drug delivery.

"We believe clinicians will appreciate the broad utility of this asset," related Sanovas CEO, Larry Gerrans. "This will be an intelligent and effective device intended to significantly improve localized, precision therapies. It is analogous to the Swiss Army Knife of Drug Delivery Catheters."

The technology measures and modulates the volumetric pressure gradients of therapeutic agent(s) within the treatment chamber(s) to perfuse the agent(s) across the tissue membrane enabling controlled delivery of the agents directly to target tissues. The system affords clinicians substantial procedural control, including the ability to select the therapeutic agent(s) of their choice and to continuously circulate, irrigate, abrade, extravasate and evacuate the treatment site while mitigating the systemic release of the agent.

"This patent is a significant cornerstone to the company's NanoVas™ portfolio of Interventional Drug Delivery Solutions," said Gerrans. "These tools are vital to the continued growth and promise of Personalized Medicine."  

Sanovas expects to commercialize the technology in coordination with its various partners to meet unmet clinical needs in Pulmonology, Cardiology, Neurology and Uro-Gynecology.

About Sanovas

Sanovas' micro-surgical technology platform is designed to give surgeons the ability to access and visualize previously inaccessible areas of the body; enabling them to diagnose, treat and deliver drug and immune therapies to small diameter anatomy in entirely new ways.

Contact for Sanovas:

Steve Goldsmith
Vice President Marketing
sgoldsmith@sanovas.com
(415) 729- 9391 ext. 1023


'/>"/>
SOURCE Sanovas, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanovas Launches Next Generation Surgical Imaging Technology
2. Sanovas Fills Corporate Bench with Industry Veterans In Clinical, Regulatory and Finance
3. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
4. WPPS GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline
5. T1D Exchange Awarded $2.8M Grant by JDRF to Study Metformin and Type 1 Diabetes
6. NanoBio Awarded Up To $10 Million In NIH Funding To Develop A Pandemic Influenza Vaccine
7. Pfenex Inc. awarded a subcontract by Leidos to develop a scalable cGMP production process for a second key malaria antigen
8. AMRI Awarded Development and Manufacture Contract from the UK Government
9. Numotion Awarded Best Complex Rehab Provider
10. Isis Pharmaceuticals Stanley Crooke Awarded Corporate Forums Director of the Year
11. Access Pharmaceuticals Awarded Second European Patent for MuGard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):